Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

Inclusion Criteria: * Adult patients with end stage renal disease undergoing kidney transplantation with a deceased or living donor kidney. * Absence of diabetes prior to kidney transplantation, defined according to American Diabetes Association guideline (not on oral hypoglycemic agents or insulin with fasting glucose \<126 mg/dL). * Receiving standard triple immunosuppressive medications that include tacrolimus, mycophenolate mofetil or mycophenolic sodium and steroids. * Capable of understanding the study and willing to give informed written consent for study participation. Exclusion Criteria: * Patients with a diagnosis of diabetes mellitus prior to kidney transplantation, or receiving anti-diabetic medications, or having pre-transplant fasting glucose level equal or greater than 126 mg/dL on two occasions at least three days apart. * Patients receiving an organ transplant other than kidney. * Patients receiving an unlicensed drug or therapy within one month prior to study entry. * Patients with history of hypersensitivity to injectable insulin. * Patients with documented HIV infection.